Physician

Daniel Orme, MD

According to 2025 Medicare claims, Daniel Orme, MD (NPI: 1922660950) practices neurology in the Salt Lake City-Murray, UT market, with the plurality of this provider's patient population coming from Salt Lake, UT. This provider's primary affiliated billing organization is DR JOHN FOLEY LLC (NPI: 1437330974; TIN: 010759642) and primary practice location at 84103-2895.

Orme's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 24 traditional Medicare patients, billed 4,182 HCPCS/CPT codes, and received $76,027 in Medicare payments. The top billing code was 96365 (Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less). Part D data shows 158 prescription claims across 69 beneficiaries totaling $40,927 in drug costs, led by Pregabalin (Pregabalin). Open Payments data shows 45 records totaling $1,253. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,451 to $40,927. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$38K$76K2024 Medicare payment: $76,027 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024244,182$76,027

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$20K$41K2019 Drug cost: $3,451 (USD; Tot_Drug_Cst)2020 Drug cost: $8,549 (USD; Tot_Drug_Cst)2021 Drug cost: $12,032 (USD; Tot_Drug_Cst)2022 Drug cost: $7,685 (USD; Tot_Drug_Cst)2023 Drug cost: $15,623 (USD; Tot_Drug_Cst)2024 Drug cost: $40,927 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20191534$3,451
20202570$8,549
20211987$12,032
20222558$7,685
202332116$15,623
202469158$40,927

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less1515$46
J2323Injection, natalizumab, 1 mg163,903$19

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
PregabalinPregabalin13390$520
GabapentinGabapentin261,452$448
BaclofenBaclofen271,170$398

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.45$1,253ANI Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Daniel Orme, MD?

Tedicare shows public-source Medicare data for Daniel Orme, MD (NPI 1922660950), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Orme, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel Orme, MD?

Daniel Orme, MD is linked to DR JOHN FOLEY LLC (billing NPI 1437330974) in the available physician profile data.

Does Daniel Orme, MD have Open Payments data?

Daniel Orme, MD has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.